| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 94/09/15 | 103/01/17 | 黃國龍 | 黃國龍 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.01(Q2) | 0 | 10.86 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 20,910,392 | 716,844,175 | ||
| 主要經營業務 | |||
| 新藥研發 | |||
| 公司網址 | |||
| taigenbiotech.com/ | |||
太景*-KY(4157) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 2,750 | 1,182 | -38.3% | 132.6% | 112,439 | 14,740 | 662.8% |
| 2023/07 | 4,457 | 1,193 | -29.4% | 273.6% | 109,689 | 13,558 | 709% |
| 2023/06 | 6,311 | 1,005 | -93.1% | 528% | 105,232 | 12,365 | 751% |
| 2023/05 | 91,286 | 870 | 4776.4% | 10392.6% | 98,921 | 11,360 | 770.8% |
| 2023/04 | 1,872 | 812 | 5.6% | 130.5% | 7,635 | 10,490 | -27.2% |
| 2023/03 | 1,772 | 812 | 51.2% | 118.2% | 5,763 | 9,678 | -40.5% |
| 2023/02 | 1,172 | 7,097 | -58.4% | -83.5% | 3,991 | 8,866 | -55% |
| 2023/01 | 2,819 | 1,769 | 107.7% | 59.3% | 2,819 | 1,769 | 59.3% |
| 2022/12 | 1,357 | 15 | -14.2% | 8946.7% | 36,231 | 1,294,523 | -97.2% |
| 2022/11 | 1,581 | 796 | -11.5% | 98.6% | 34,874 | 1,294,508 | -97.3% |
| 2022/10 | 1,787 | 719 | -89.3% | 148.5% | 33,293 | 1,293,712 | -97.4% |
| 2022/09 | 16,766 | 1,362 | 1318.4% | 1131% | 31,506 | 1,292,993 | -97.6% |
| 2022/08 | 1,182 | 445 | -0.9% | 165.6% | 14,740 | 1,291,631 | -98.8% |
| 2022/07 | 1,193 | 549 | 18.7% | 117.3% | 13,558 | 1,291,186 | -98.9% |
| 2022/06 | 1,005 | 916,884 | 15.5% | -99.9% | 12,365 | 1,290,637 | -99% |
| 2022/05 | 870 | 427 | 7.1% | 103.7% | 11,360 | 373,753 | -97% |
| 2022/04 | 812 | 327,176 | 0% | -99.8% | 10,490 | 373,326 | -97.2% |
| 2022/03 | 812 | 639 | -88.6% | 27.1% | 9,678 | 46,150 | -79% |
| 2022/02 | 7,097 | 40,348 | 301.2% | -82.4% | 8,866 | 45,511 | -80.5% |
| 2022/01 | 1,769 | 5,163 | 11693.3% | -65.7% | 1,769 | 5,163 | -65.7% |
| 2021/12 | 15 | 3,775 | -98.1% | -99.6% | 1,294,523 | 23,422 | 5427% |
| 2021/11 | 796 | 2,119 | 10.7% | -62.4% | 1,294,508 | 19,647 | 6488.8% |
| 2021/10 | 719 | 2,621 | -47.2% | -72.6% | 1,293,712 | 17,528 | 7280.8% |
| 2021/09 | 1,362 | 942 | 206.1% | 44.6% | 1,292,993 | 14,907 | 8573.7% |
| 2021/08 | 445 | 1,194 | -18.9% | -62.7% | 1,291,631 | 13,965 | 9149% |
| 2021/07 | 549 | 1,953 | -99.9% | -71.9% | 1,291,186 | 12,771 | 10010.3% |
| 2021/06 | 916,884 | 1,905 | 214626.9% | 48030.4% | 1,290,637 | 10,818 | 11830.5% |
| 2021/05 | 427 | 1,773 | -99.9% | -75.9% | 373,753 | 8,913 | 4093.3% |
| 2021/04 | 327,176 | 3,819 | 51101.3% | 8467% | 373,326 | 7,140 | 5128.6% |
| 2021/03 | 639 | 236 | -98.4% | 170.8% | 46,150 | 3,321 | 1289.6% |
| 2021/02 | 40,348 | 1,819 | 681.5% | 2118.1% | 45,511 | 3,085 | 1375.2% |
| 2021/01 | 5,163 | 1,266 | 36.8% | 307.8% | 5,163 | 1,266 | 307.8% |
| 2020/12 | 3,775 | 1,237 | 78.2% | 205.2% | 23,422 | 20,808 | 12.6% |
| 2020/11 | 2,119 | 569 | -19.1% | 272.4% | 19,647 | 19,571 | 0.4% |
| 2020/10 | 2,621 | 5,505 | 178.2% | -52.4% | 17,528 | 19,002 | -7.8% |
| 2020/09 | 942 | 1,602 | -21.1% | -41.2% | 14,907 | 13,497 | 10.4% |
太景*-KY(4157) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 1625.99% | 299.49% | 2020Q3 | -45.46% | -3.10% |
| 2023Q1 | 21.97% | -10.81% | 2020Q2 | 125.75% | 17.09% |
| 2022Q4 | -75.31% | 9.67% | 2020Q1 | -54.58% | -5.90% |
| 2022Q3 | 612.36% | 103.29% | 2019Q4 | 52.34% | 14.44% |
| 2022Q2 | -72.24% | -98.71% | 2019Q3 | 15.64% | 6.21% |
| 2022Q1 | 532.55% | -2.82% | 2019Q2 | -8.75% | 5.89% |
| 2021Q4 | -35.06% | -0.54% | 2019Q1 | -2.94% | -43.07% |
| 2021Q3 | -99.81% | -0.13% | 2018Q4 | 25.43% | 7.82% |
| 2021Q2 | 2596.61% | 1867.13% | 2018Q3 | 16.86% | -14.32% |
| 2021Q1 | 441.98% | 182.86% | 2018Q2 | -80.95% | -94.48% |
| 2020Q4 | 108.24% | 5.42% | 2018Q1 | 539.28% | 0.84% |
評論0